Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori–infected adults

This publication has 30 references indexed in Scilit:

• Treatment of Helicobacter pylori
  Current Opinion in Gastroenterology, 1998
• Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection
  The Lancet, 1996
• Antimicrobial resistance and Helicobacter pylori
  Journal of Antimicrobial Chemotherapy, 1996
• Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
  Vaccine, 1996
• Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection
  The Lancet, 1995
• Galactose‐binding site in Escherichia coli heat‐labile enterotoxin (LT) and cholera toxin (CT)
  Molecular Microbiology, 1994
• Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization
  Vaccine, 1993
• Immunisation against gastric infection with Helicobacter species: First step in the prophylaxis of gastric cancer?
  Zentralblatt für Bakteriologie, 1993
• Protection by human milk IgA against Helicobacter pylori infection in infancy
  The Lancet, 1993
• Cross-Protection by B Subunit-Whole Cell Cholera Vaccine Against Diarrhea Associated with Heat-Labile Toxin-Producing Enterotoxigenic Escherichia coli: Results of a Large-Scale Field Trial
  The Journal of Infectious Diseases, 1988